Group 1 - The total subscription funds for Saiying Electronics are approximately 660 billion, which is a decrease of 2,284 billion compared to the previous similar subscription limit of Yuelong Technology at 888.4 billion [1] - The announcement for Shanbo Convertible Bond indicates that there will be no adjustment [2] - Chuangda New Materials is listed for subscription on the Beijing Stock Exchange [1] Group 2 - A table of convertible bonds is provided, detailing their current prices, redemption prices, last trading dates, last conversion dates, conversion values, remaining scales, and the proportion of convertible bonds to the underlying stocks [5] - Specific convertible bonds listed include: - Li Qun Convertible Bond with a current price of 109.733 and a remaining scale of 699.5 million, accounting for 17.69% of the underlying stock [5] - Dong Shi Convertible Bond with a current price of 90.079 and a remaining scale of 95.1 million, accounting for 3.55% of the underlying stock [5] - Lu Tai Convertible Bond with a current price of 110.835 and a remaining scale of 1.3982 billion, accounting for 33.80% of the underlying stock [5]

Group 1 - Taiping Bird's shareholders plan to reduce their holdings by no more than 3% [1] - Yinxin Technology's shareholders plan to collectively reduce their holdings by no more than 2.9% [1] - Jin Hong Convertible Bond and Yi Wei Convertible Bond are subject to strong redemption [1] Group 2 - The listing of Longyuan Co., Ltd. on the Beijing Stock Exchange [1] - Details of various convertible bonds including their current prices, redemption prices, last trading dates, and conversion values [2][4][6]

Core Viewpoint - The article discusses recent developments in convertible bonds, including price adjustments, shareholder actions, and new listings in the market [5][7]. Summary by Sections Convertible Bond Announcements - The announcement regarding the adjustment of the Wei Ning convertible bond (转债代码: 123104) was made on March 27, 2026 [2]. Current Prices and Key Metrics of Convertible Bonds - The current prices and metrics of various convertible bonds are detailed, including: - Li Yang Convertible Bond (转债代码: 118048) has a current price of 165.531, a strong redemption price of 100.298, and a conversion value of 166.38 with a remaining scale of 0.035 billion [4]. - Feng Gong Convertible Bond (转债代码: 123239) has a current price of 112.400, a strong redemption price of 100.156, and a conversion value of 113.39 with a remaining scale of 0.083 billion [4]. - Bai Chuan Convertible Bond 2 (转债代码: 127075) has a current price of 172.000, a strong redemption price of 100.809, and a conversion value of 173.97 with a remaining scale of 0.317 billion [4]. - Other notable bonds include Wei Ce Convertible Bond (转债代码: 118055) with a current price of 203.061 and a remaining scale of 1.962 billion, and Hai You Convertible Bond (转债代码: 118008) with a current price of 105.945 and a remaining scale of 1.645 billion [4]. Shareholder Actions - Micro Nano (微导纳米) plans to transfer 2.5% of its shares through a pricing inquiry [5]. - Long Da Food (龙大美食) has had 9.27 million shares frozen by judicial order [5]. - Five Continents Special Paper (五洲特纸) intends to reduce its holdings by a total of 1.32% [5]. - Yong Jin Shares (甬金股份) received a warning letter for violating trading regulations during a window period [5]. - San Nuo Bio (三诺生物) plans to repurchase shares worth between 150 million to 300 million [5]. - Shan Shi Network Technology (山石网科) reported a projected net loss of approximately 194 million for 2025 [5]. New Listings and Subscriptions - New listings include Yue Long Technology (悦龙科技) on the Beijing Stock Exchange and You Yan Composite Materials (有研复材) on the Shanghai and Shenzhen stock exchanges [5].

Group 1 - The article discusses the adjustment of convertible bonds, specifically highlighting that Hongtu Convertible Bond will undergo a downward adjustment while Lezhi Convertible Bond will not [1][2]. - Hongtu Convertible Bond (code: 118027) has announced a downward adjustment on March 19, 2026 [2]. - Lezhi Convertible Bond (code: 127062) has confirmed it will not undergo any adjustment on the same date [2]. Group 2 - The current price of Hongtu Convertible Bond is 192.679, with a strong redemption price of 100.373, and it has a remaining scale of 0.101 billion [4]. - Other convertible bonds listed include Songlin Convertible Bond with a current price of 216.685 and a remaining scale of 0.012 billion, and Zmengsheng Convertible Bond priced at 195.023 with a remaining scale of 0.113 billion [4]. - The article provides a detailed table of various convertible bonds, including their current prices, redemption prices, last trading dates, last conversion dates, conversion values, remaining scales, and the proportion of convertible bonds to the underlying stocks [4][6].

Group 1 - The article discusses a fire incident at a wholly-owned subsidiary of Kaitian New Materials, which has been ordered to suspend production [1] - The article mentions the subscription of new shares for companies such as Puang Medical and Zuxing New Materials listed on the Beijing Stock Exchange [1] - It provides a list of convertible bonds, including their current prices, redemption prices, last trading dates, and conversion values [4][5][7] Group 2 - The article highlights that Yongji Co., the controlling shareholder, plans to reduce its stake by no more than 2% [5] - It notes that Lidong New Materials intends to invest 280 million yuan to expand its battery aluminum foil project [5] - The article states that the Zhongte convertible bond will not undergo a reset [5]

Core Viewpoint - Jianyou Co., Ltd. announced that it will not adjust the conversion price of its convertible bonds despite triggering the downward adjustment clause due to stock prices falling below 90% of the conversion price for 15 out of 30 trading days [2] Group 1 - As of December 12, 2025, Jianyou Co., Ltd. has experienced a situation where the closing price of its stock has been below 90% of the current conversion price for 15 trading days [2] - The company's board of directors decided not to proceed with a downward adjustment of the conversion price at this time [2] - The company has set a future period of four months, from December 13, 2025, to April 12, 2026, during which it will also not propose a downward adjustment if the clause is triggered again [2]

Group 1 - The company, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., issued 5,031,900 convertible bonds with a total amount of RMB 503.19 million, which are set to mature on April 22, 2026 [1] - The initial conversion price of the convertible bonds was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing it down to RMB 24.54 per share as of July 7, 2023 [2] - The company’s board has the authority to propose a downward adjustment of the conversion price if the stock price falls below 90% of the current conversion price for at least 15 out of 30 consecutive trading days [3] Group 2 - The company decided not to adjust the conversion price of the convertible bonds during the upcoming six months, even if the conditions for adjustment are met [4] - If the stock price continues to fall and triggers the adjustment conditions after November 24, 2025, the board will reconvene to decide on the potential adjustment [5]

Core Viewpoint - The announcement details the conversion results of the "Jianyou Convertible Bonds" and the changes in the company's share capital as of June 30, 2025, highlighting the low conversion rate and the significant amount of unconverted bonds [1][2][3]. Summary by Sections Conversion Situation - As of June 30, 2025, a total of RMB 719,000 worth of "Jianyou Convertible Bonds" has been converted into common shares, resulting in 18,035 shares, which represents 0.001% of the total shares before conversion [2][6]. - The total amount of "Jianyou Convertible Bonds" that has not been converted is RMB 502,464,000, accounting for 99.86% of the total issuance [3][6]. Convertible Bond Issuance Overview - The company issued 5,031,900 convertible bonds with a total value of RMB 503.19 million, with a maturity of 6 years, approved by the China Securities Regulatory Commission [4]. - The bonds were listed on the Shanghai Stock Exchange on May 22, 2020, under the code "113579" [4]. Conversion Price Adjustments - The initial conversion price was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing the price to RMB 24.34 per share as of June 5, 2025 [5].

Summary of Key Points Core Viewpoint - The announcement details the conversion results and share changes related to the "Jianyou Convertible Bonds" issued by Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd, highlighting the low conversion rate and the remaining unconverted bonds. Group 1: Conversion Status - As of June 30, 2025, a total of RMB 719,000 of "Jianyou Convertible Bonds" have been converted into ordinary shares, with RMB 7,000 of the bonds being repurchased [1][3] - The amount of unconverted "Jianyou Convertible Bonds" as of June 30, 2025, is RMB 502,464,000, which represents 99.86% of the total issuance [1][3] Group 2: Issuance Overview - The company issued 5,031,900 convertible bonds with a total value of RMB 5.0319 billion, with a maturity of 6 years, approved by the China Securities Regulatory Commission [1][2] - The bonds were listed on the Shanghai Stock Exchange starting from May 22, 2020, under the code "113579" [1][2] Group 3: Conversion Price Adjustments - The initial conversion price was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing the price down to RMB 24.34 per share effective from June 5, 2025 [2][3] Group 4: Share Capital Changes - The total share capital remained unchanged at 1,615,634,969 shares as of June 30, 2025, with no new shares issued from the conversion of the bonds [4]

Group 1 - The core viewpoint of the announcement is that the credit rating for Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.'s convertible bonds remains unchanged at "AA" with a stable outlook [2][3]. - The previous rating for "Jianyou Convertible Bonds" was also "AA" with a stable outlook, indicating consistency in the company's creditworthiness [3]. - The tracking credit rating was conducted by United Credit Rating Co., Ltd., which assessed the company's business, management, and financial situation before issuing the report on June 27, 2025 [3]. Group 2 - The announcement confirms that the company's credit rating and the rating for the convertible bonds have not changed since the last assessment on June 26, 2024 [2][3]. - The report is available for further details on the Shanghai Stock Exchange website [3]. - The announcement was officially made by the board of directors of Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. on June 28, 2025 [5].